Viewing Study NCT06984627


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-05 @ 7:09 PM
Study NCT ID: NCT06984627
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graves' Disease View
Keywords: